Search Results 91-100 of 3495 for Solid

  1. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    About this study. The purpose of the trial is to establish the tolerability of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors.

  2. INCB161734 for Advanced or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.

  3. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

    Clinical Trials · Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study.

  4. Mayo Clinic Q&A podcast: 2020 was a record year for solid organ transplants, even amid COVID-19 pandemic

    Despite the COVID-19 pandemic the center performed the most solid organ transplants across its three campuses in Arizona, Florida and Minnesota, than any time ...

  5. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

    The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express epidermal growth factor receptor (EGFR).

  6. PGY-2 Pharmacy Residency in Solid Organ Transplant at Mayo Clinic Hospital — Arizona - Meet The Faculty

    After completing residency, I returned to sunny Arizona as a Clinical Specialist Pharmacist in the Solid Organ Transplant Department at Mayo Clinic in Arizona.

  7. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

    ... solid tumors in phase 1. Primary objective of Phase 1b is to assess overall response rate (ORR) determined by Investigator per RECIST v1.1 for patients in ...

  8. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

    This Phase 1/2 study will enroll patients with various advanced solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and ...

  9. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

    Patients in the study will be treated with Melphalan/HDS and will receive up to 6 total treatments. This study will evaluate the safety and effects of the ...

  10. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

    ... solid tumors and multiple myeloma with genetic abnormalities. The progression of cancers is caused by a complex series of multiple genetic and molecular ...